Sourcing Cannabis Lawfully for CBD Consumer Products: Challenges and Opportunities
Update Magazine | Spring 2021
The Approaching Bioengineered Food Disclosure Deadline: Enforcement and Litigation Landscape After January 1, 2022
Update Magazine | Spring 2021
2020 Year in Review—Canada’s Top 10 Drug and Vaccine Regulatory Updates
Update Magazine | Spring 2021
Will 2021 Be a Pivotal Year for the CBD Industry? A Look at the Regulatory Landscape and Potential for Change
Update Magazine | Spring 2021
The Tobacco Industry and the Scientific Community: A Public Health Response
Update Magazine | Spring 2021
The WTO’s Decision on Australia’s Plain Packaging Tobacco Measures Explained
Update Magazine | Spring 2021
The Question of Mitigating Patient Mortality: Comparing Gilead’s ACTT-1 and the WHO’s Solidarity Trials
Update Magazine | Winter 2020
A Look Back at Risk Evaluation and Mitigation Strategies at the Food and Drug Administration in 2020: Year in Review
Update Magazine | Winter 2020
Regulations of CAR T-Cell Therapies—The Past, Present, and Future
Update Magazine | Winter 2020
Antitrust Treatment of Acceleration Provisions in Hatch-Waxman Settlements
Update Magazine | Winter 2020
